Literature DB >> 24234672

Folic acid and the prevention of neural tube defects: A position paper of the national society of genetic counselors.

B J Baty1, L Cohen, L Phelps, M C Speer, P Stengel, L Williamson-Kruse.   

Abstract

Considerable scientific evidence demonstrates the reduction in risk for neural tube defects (NTDs) associated with maternal preconceptional folic acid supplementation. The National Society of Genetic Counselors (NSGC) endorses the U.S. Public Health Service recommendations for folic acid supplementation at the 0.4 mg level for women in the general population and at the 4.0 mg level for women at high or increased risk for NTD pregnancies for at least 4 weeks prior to active pursuit of conception. We encourage targeted educational efforts and surveillance to assess results of this dietary supplementation. The NSGC further urges the Food and Drug Administration to fortify staple foodstuffs with folic acid for a population-based approach to minimize the number of NTD births.

Entities:  

Year:  1996        PMID: 24234672     DOI: 10.1007/BF01408658

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  17 in total

1.  Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-08-02       Impact factor: 17.586

2.  The long-term evaluation of folic acid in the treatment of pernicious anemia.

Authors:  S O SCHWARTZ; S R KAPLAN; B E ARMSTRONG
Journal:  J Lab Clin Med       Date:  1950-06

3.  Primary prevention of neural tube defects with folic acid supplementation: Cuban experience.

Authors:  R G Vergel; L R Sanchez; B L Heredero; P L Rodriguez; A J Martinez
Journal:  Prenat Diagn       Date:  1990-03       Impact factor: 3.050

4.  Food Additives Permitted for Direct Addition to Food for Human Consumption; Folic Acid. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-04-15

5.  Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip.

Authors:  M Tolarova
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

6.  Folic acid and pregnancy.

Authors:  B F Crandall; V L Corson; J D Goldberg; G Knight; I S Salafsky
Journal:  Am J Med Genet       Date:  1995-01-02

Review 7.  Folic acid in the prevention of neural tube defects.

Authors:  A E Czeizel
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-01       Impact factor: 2.839

Review 8.  Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-09-11

9.  Periconceptional use of multivitamins and the occurrence of neural tube defects.

Authors:  J Mulinare; J F Cordero; J D Erickson; R J Berry
Journal:  JAMA       Date:  1988-12-02       Impact factor: 56.272

10.  Homocysteine metabolism in pregnancies complicated by neural-tube defects.

Authors:  J L Mills; J M McPartlin; P N Kirke; Y J Lee; M R Conley; D G Weir; J M Scott
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

View more
  2 in total

1.  Complex Genetic Disorders: Evaluating When Genetic Research Findings Are Applicable for Genetic Counseling Practice.

Authors:  C M Wolpert; E C Melvin; M C Speer
Journal:  J Genet Couns       Date:  1999-04       Impact factor: 2.537

2.  Update and Review: Maternal Serum Screening.

Authors:  K E Ormond
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.